X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs J.B.CHEMICALS - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD J.B.CHEMICALS BIOCON LTD/
J.B.CHEMICALS
 
P/E (TTM) x 37.6 13.9 270.2% View Chart
P/BV x 5.0 2.2 227.1% View Chart
Dividend Yield % 1.5 0.2 840.1%  

Financials

 BIOCON LTD   J.B.CHEMICALS
EQUITY SHARE DATA
    BIOCON LTD
Mar-16
J.B.CHEMICALS
Mar-16
BIOCON LTD/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs496318 155.8%   
Low Rs397200 198.7%   
Sales per share (Unadj.) Rs174.3148.0 117.8%  
Earnings per share (Unadj.) Rs44.819.1 234.8%  
Cash flow per share (Unadj.) Rs56.923.9 237.7%  
Dividends per share (Unadj.) Rs5.000.50 1,000.0%  
Dividend yield (eoy) %1.10.2 580.1%  
Book value per share (Unadj.) Rs202.8128.9 157.3%  
Shares outstanding (eoy) m200.0084.82 235.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.7 146.4%   
Avg P/E ratio x10.013.6 73.4%  
P/CF ratio (eoy) x7.810.8 72.5%  
Price / Book Value ratio x2.22.0 109.6%  
Dividend payout %11.22.6 425.9%   
Avg Mkt Cap Rs m89,22021,951 406.4%   
No. of employees `0004.42.7 161.5%   
Total wages/salary Rs m6,3631,841 345.6%   
Avg. sales/employee Rs Th7,894.54,590.9 172.0%   
Avg. wages/employee Rs Th1,441.2673.4 214.0%   
Avg. net profit/employee Rs Th2,029.7592.1 342.8%   
INCOME DATA
Net Sales Rs m34,85412,551 277.7%  
Other income Rs m845542 156.0%   
Total revenues Rs m35,69913,093 272.7%   
Gross profit Rs m8,2002,055 399.1%  
Depreciation Rs m2,423412 587.5%   
Interest Rs m10296 106.6%   
Profit before tax Rs m6,5202,088 312.2%   
Minority Interest Rs m-7440 186,000.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5,7540-   
Tax Rs m2,569469 547.7%   
Profit after tax Rs m8,9611,619 553.6%  
Gross profit margin %23.516.4 143.7%  
Effective tax rate %39.422.5 175.4%   
Net profit margin %25.712.9 199.4%  
BALANCE SHEET DATA
Current assets Rs m39,9327,778 513.4%   
Current liabilities Rs m16,2764,358 373.5%   
Net working cap to sales %67.927.2 249.1%  
Current ratio x2.51.8 137.5%  
Inventory Days Days5455 98.0%  
Debtors Days Days8680 107.7%  
Net fixed assets Rs m39,1015,713 684.5%   
Share capital Rs m1,000170 589.6%   
"Free" reserves Rs m38,59110,547 365.9%   
Net worth Rs m40,55610,937 370.8%   
Long term debt Rs m20,7240-   
Total assets Rs m84,81615,574 544.6%  
Interest coverage x64.922.8 284.5%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.40.8 51.0%   
Return on assets %10.711.0 97.1%  
Return on equity %22.114.8 149.3%  
Return on capital %19.020.0 95.1%  
Exports to sales %30.748.7 63.1%   
Imports to sales %20.47.1 287.9%   
Exports (fob) Rs m10,7176,115 175.3%   
Imports (cif) Rs m7,105889 799.5%   
Fx inflow Rs m11,7896,169 191.1%   
Fx outflow Rs m8,3931,285 653.1%   
Net fx Rs m3,3964,884 69.5%   
CASH FLOW
From Operations Rs m5,2641,397 376.9%  
From Investments Rs m-9,540-320 2,978.5%  
From Financial Activity Rs m10,867-1,196 -908.8%  
Net Cashflow Rs m6,591-102 -6,442.8%  

Share Holding

Indian Promoters % 40.4 55.4 72.9%  
Foreign collaborators % 20.6 0.3 6,866.7%  
Indian inst/Mut Fund % 8.4 3.4 247.8%  
FIIs % 10.7 3.9 274.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 37.0 53.8%  
Shareholders   109,995 30,437 361.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare BIOCON LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD 8-QTR ANALYSIS

COMPARE BIOCON LTD WITH

MARKET STATS